EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Flubendazole reduces emerging Dracunculus medinensis in dogs in Chad: Results from a two-year study

Amy C Dupper iD, Charles D Mackenzie, Timothy G Geary, Deborah L Elder, Wided Najahi-Missaoui, Christopher A Cleveland, Ellen K Haynes, Michael J Yabsley, Guilherme Gomes Verocai, Macon Overcast, John A Bryan Ii, Fernando Torres-Velez und 5 weitere

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Amy C Dupper und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America. Hauptthemen laut MEDLINE: Anthelmintics, Dog Diseases, Dracunculiasis, Dracunculus Nematode. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Carter Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since being targeted for eradication in the 1980s, global human cases of dracunculiasis (Guinea worm disease; GWD) have been reduced by over 99.9% through interventions aimed at interrupting the life cycle of the causative parasite, Dracunculus medinensis . However, the burden of GWD in dogs is higher than in humans and other monitored mammalian host species, threatening eradication of GWD. Expanding on a previous clinical trial of flubendazole (FLBZ) in dogs in Chad, we conducted a cluster-randomized controlled trial in which half of enrolled villages (N = 29) were assigned to receive FLBZ and the other half (N = 27) to receive no treatment. An annual difference-in-differences analysis revealed that treated villages had 59.3% fewer predicted emerging D. medinensis adult females (95% CI: 53.8% fewer to 69.2% fewer) per village per year during the second year of the study compared to control villages. Analyses examining effects of FLBZ monthly, at the individual dog level, and through histopathology of D. medinensis female reproductive morphology, all support the conclusion that FLBZ inhibits embryogenesis and larval development within the uterus of gravid female worms. Together these data are consistent with a hypothesis that although D. medinensis emerged from individually treated dogs, the L1s released from dogs treated with FLBZ exhibited reduced viability, thus reducing the risk of infection in the next mammalian host. This trial builds the body of knowledge about FLBZ’s impacts on D. medinensis in the canine host and provides compelling evidence on the effectiveness of FLBZ in reducing the number of emerging D. medinensis in dogs, which can contribute to the eradication of this parasite. However, additional questions remain regarding the formulation, which need to be addressed in future studies before being deployed at scale.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthelminticsDog DiseasesDracunculiasisDracunculus NematodeMebendazoleAnimalsDogsFemaleMaleChad

Substanzen

AnthelminticsflubendazoleMebendazole

Autor:innen und Institutionen

  • Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, United States of America.
  • Institute of Parasitology, McGill University, Ste-Anne-de-Bellevue, Québec, Canada.
  • School of Biological Sciences, Queen's University-Belfast, Northern Ireland, United Kingdom.
  • Department of Pharmaceutical and Biomedical Sciences, University of Georgia, Athens, Georgia, United States of America.
  • Southeastern Cooperative Wildlife Diseases Study, University of Georgia College of Veterinary Medicine, Athens, Georgia, United States of America.
  • Center for Ecology of Infectious Diseases, University of Georgia, Athens, Georgia, United States of America.

ORCID-Profile: Amy C Dupper

Förderung

  • Carter Center

Zitieren

APA

Dupper, A. C., Mackenzie, C. D., Geary, T. G., Elder, D. L., Najahi-Missaoui, W., Cleveland, C. A., Haynes, E. K., Yabsley, M. J., Gomes Verocai, G., Overcast, M., Bryan Ii, J. A., Torres-Velez, F., Koumétio Sidouin, M., Richard Ngandolo, B. N., Tchindebet Oaukou, P., Weiss, A. J., & Garabed, R. (2026). Flubendazole reduces emerging Dracunculus medinensis in dogs in Chad: Results from a two-year study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014763

Vancouver

Dupper AC, Mackenzie CD, Geary TG, Elder DL, Najahi-Missaoui W, Cleveland CA, et al. Flubendazole reduces emerging Dracunculus medinensis in dogs in Chad: Results from a two-year study. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014763

BibTeX
@article{Dupper2026,
  author = {Dupper, Amy C and Mackenzie, Charles D and Geary, Timothy G and Elder, Deborah L and Najahi-Missaoui, Wided and Cleveland, Christopher A and Haynes, Ellen K and Yabsley, Michael J and Gomes Verocai, Guilherme and Overcast, Macon and Bryan Ii, John A and Torres-Velez, Fernando and Koumétio Sidouin, Métinou and Richard Ngandolo, Bongo Nare and Tchindebet Oaukou, Philip and Weiss, Adam J and Garabed, Rebecca},
  title = {Flubendazole reduces emerging Dracunculus medinensis in dogs in Chad: Results from a two-year study},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014763}
}
Kostenlos starten →